STE|Analyst Targets
STE|Company Info
STE|Insider Trading
STE|Fundamentals
STE|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $2.56 | - | - |
| Q1'27 | $2.53 | $2.59 | +2.5% |
| Q4'26 | $2.85 | $2.83 | -0.7% |
| Q3'25 | $2.35 | $2.47 | +5.1% |
| Q2'25 | $2.26 | $2.34 | +3.4% |
| Q1'25 | $2.60 | $2.74 | +5.4% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $1.5B | - | - |
| Q1'27 | $1.5B | $1.5B | -1.3% |
| Q4'26 | $1.6B | $1.6B | -1.4% |
| Q3'25 | - | $1.5B | - |
| Q2'25 | - | $1.4B | - |
| Q1'25 | - | $1.5B | - |
STE|Monthly Returns
Market Data
STE Stock Snapshot
- Market cap
- 21.25B
- P/E ratio
- 26.4
- Day range
- $215.70 – $220.01
- News sentiment
- 81/100 · Bullish
- Analyst target
- $262.14 (+20.7%)
- Consensus
- Buy · 18 analysts
STE's technical picture is under pressure, with momentum working against price. Institutional coverage is thorough here, so shifts in analyst expectations show up in price quickly.
Behaviour On Record
What STE's own history says about today's numbers
- Realized volatility (21d)
- 14.4% 19th pct
- Below its peak
- -18.3%
- vs 200-day average
- -3.2%
- Up days (1y)
- 48%
STERIS plc is currently running 14.4% annualised volatility over the last 21 sessions. Measured against STE's own 13 years of daily returns rather than a market-wide average, that is the 19th percentile — unusually subdued by its own history, against a typical reading of 20.8%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.
STE is trading -18.3% below its running peak. Across 12 full years on file, its median worst-drawdown-in-a-year was -15.4%, and the deepest was -36.5% in 2022. The current drawdown is already deeper than this stock's typical annual low point, which puts it in the part of its range where past recoveries began — and where past declines also continued.
Price sits -3.2% from its 200-day moving average. Against every other day in its history, that gap ranks at the 16th percentile — a narrower gap than it typically runs. Over the past year STE closed higher on 48% of sessions, and it is currently 1 session into a rising streak.
On October specifically: over 14 years of records, STE finished the month higher 9 of 14 times, with a median return of +1.1% and an average of +2.4%. Its strongest month historically has been May at +4.3% on average, its weakest September at -1.8%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.
Overnight risk is measurable too: STE has opened more than 2% away from the prior close in 67 of 3,268 sessions (2.1% of the time), with the largest gaps running +6.1% and -8.6%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.
Across the last 3 dated reports on file, STE moved an average of 1.8% in the session after earnings, closing higher 3 of those 3 times, with a median move of +0.8% and a largest of +4.4%.
All figures computed from 3,269 daily closes between 2013-10-15 and 2026-10-14, split-adjusted, recomputed daily. Percentiles are against STE's own 13-year history, not a peer group or index.
Sector Rotation
Is money rotating into or out of STE's sector?
STERIS plc sits in the Health Care sector, currently ranked 2nd of 12 GICS sectors by relative-strength rotation score (leading). Within its narrower Medical Devices industry group, STE ranks 2nd of 15 tracked industries, leading.
- Sector rank
- #2 of 12
- Sector state
- Leading
- Sector rotation score
- 82
- Industry rank
- #2 of 15
Analyst Rating Changes
Are analysts turning bullish or bearish on STE?
UBS most recently reiterated its rating on STERIS plc to Buy on Aug 7, 2026 with a price target of $270 (from $275). Over the last 90 days, coverage has run 0 upgrades against 0 downgrades, a net mixed lean.
- Latest action
- UBS — Buy
- 90-day upgrades
- 0
- 90-day downgrades
- 0
- Net rating momentum
- 0
Peers & ETF holders
STE peers & ETF holders
Medical DevicesMarket cap · today
News Sentiment Analysis
Sentiment gathered from recent headlines
Recent News Coverage
Most recent articles, ranked by recency (click to expand).
Technical Analysis
Real-time indicators across multiple timeframes
| Manager | Trend | Shares Held | % of Co. | Position Value | Filed |
|---|---|---|---|---|---|
| Brevan Howard Capital Management LP | ▲ Buy | 20,654 | 0.02% | $4.35M | 2026-08-14 |
| Schonfeld Strategic Advisors LLC | ▲ Buy | 2,882 | 0.00% | $606.9K | 2026-08-14 |
| Graham Capital Management, L.P. | ▲ New | 2,850 | 0.00% | $600.1K | 2026-08-14 |
| Ancora Advisors LLC | ▲ Buy | 1,688 | 0.00% | $355.4K | 2026-08-14 |
| Winton Group Ltd | ▼ Sold out | 0 | 0.00% | $0 | 2026-08-07 |
| Member | Chamber | State | Type | Amount | Traded | Filed |
|---|---|---|---|---|---|---|
| Kevin Hern | House | OK01 | ▼ Sell | $15K - $50K | 2026-09-15 | 2026-09-25 |
| April McClain Delaney | House | MD06 | ▼ Sell | $100K - $250K | 2026-08-25 | 2026-09-09 |
| April McClain Delaney | House | MD06 | ▼ Sell | $1K - $15K | 2026-07-31 | 2026-08-03 |
| April McClain Delaney | House | MD06 | ▼ Sell | $1K - $15K | 2026-07-29 | 2026-08-03 |
| April McClain Delaney | House | MD06 | ▼ Sell | $1K - $15K | 2026-07-27 | 2026-08-03 |
| April McClain Delaney | House | MD06 | ▼ Sell | $1K - $15K | 2026-07-24 | 2026-08-03 |
| Jared Moskowitz | House | FL23 | ▼ Sell | $1K - $15K | 2026-07-13 | 2026-08-27 |
| Gilbert Cisneros | House | CA31 | ▲ Buy | $1K - $15K | 2026-05-13 | 2026-06-08 |
| Gilbert Cisneros | House | CA31 | ▲ Buy | $1K - $15K | 2026-05-11 | 2026-06-08 |
| Gilbert Cisneros | House | CA31 | ▲ Buy | $1K - $15K | 2026-05-01 | 2026-05-08 |
| April McClain Delaney | House | MD06 | ▲ Buy | $1K - $15K | 2026-04-30 | 2026-05-06 |
| April McClain Delaney | House | MD06 | ▲ Buy | $1K - $15K | 2026-03-16 | 2026-04-06 |
| Gilbert Cisneros | House | CA31 | ▲ Buy | $1K - $15K | 2026-02-10 | 2026-03-09 |
| April McClain Delaney | House | MD06 | ▲ Buy | $1K - $15K | 2026-02-06 | 2026-03-10 |
| April McClain Delaney | House | MD06 | ▲ Buy | $1K - $15K | 2025-09-18 | 2025-10-06 |
| April McClain Delaney | House | MD06 | ▲ Buy | $1K - $15K | 2025-09-11 | 2025-10-06 |
| April McClain Delaney | House | MD06 | ▼ Sell | $1K - $15K | 2025-06-26 | 2025-07-02 |
| Rob Bresnahan | House | PA08 | ▲ Buy | $1K - $15K | 2025-02-25 | 2025-03-27 |
| Susan M. Collins | Senate | ME | ▼ Sell | $1K - $15K | 2014-07-23 | 2015-07-20 |